Received Jun 14, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Z27PB | — |
gave a 2 years old an adult dose of the Havrix the Hepatitis A vaccine as supposed to be a pediatric dose; gave a 2 years old an adult dose of the Havrix the Hepatitis A vaccine as supposed to be a pediatric dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 2-year-old female patient who received HAV (Havrix 1440 adult) suspension for injection in pre-filled syringe (batch number Z27PB with expiry date 27-AUG-2026) for prophylaxis. On 08-JUN-2026, the patient received Havrix 1440 adult. On 08-JUN-2026, an unknown time after receiving Havrix 1440 adult, the patient experienced adult product administered to child (Verbatim: gave a 2 years old an adult dose of the Havrix the Hepatitis A vaccine as supposed to be a pediatric dose) and overdose (Verbatim: gave a 2 years old an adult dose of the Havrix the Hepatitis A vaccine as supposed to be a pediatric dose). The outcome of the adult product administered to child and overdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-JUN-2026 The reporter stated at a private practice doctor's office and they administer vaccines, gave a 2 years old an adult dose of the Havrix, the Hepatitis A vaccine as supposed to be a pediatric dose, so he had one ml of the hepatitis A instead of the 0.5 ml.